Mark Bartholomä

3.0k total citations
87 papers, 2.2k citations indexed

About

Mark Bartholomä is a scholar working on Radiology, Nuclear Medicine and Imaging, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Mark Bartholomä has authored 87 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Radiology, Nuclear Medicine and Imaging, 47 papers in Pulmonary and Respiratory Medicine and 45 papers in Oncology. Recurrent topics in Mark Bartholomä's work include Radiopharmaceutical Chemistry and Applications (61 papers), Prostate Cancer Treatment and Research (43 papers) and Peptidase Inhibition and Analysis (25 papers). Mark Bartholomä is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (61 papers), Prostate Cancer Treatment and Research (43 papers) and Peptidase Inhibition and Analysis (25 papers). Mark Bartholomä collaborates with scholars based in Germany, United States and Switzerland. Mark Bartholomä's co-authors include Jon Zubieta, John F. Valliant, Samer Ezziddin, Florian Rosar, Stephan Maus, Fadi Khreish, Tobias Stemler, Friederike Braun, John W. Babich and Johannes Linxweiler and has published in prestigious journals such as Chemical Reviews, Chemical Communications and Scientific Reports.

In The Last Decade

Mark Bartholomä

79 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Bartholomä Germany 25 1.5k 931 872 269 252 87 2.2k
Cathy S. Cutler United States 23 1.6k 1.1× 554 0.6× 443 0.5× 444 1.7× 277 1.1× 67 2.5k
Licia Uccelli Italy 26 1.3k 0.9× 621 0.7× 433 0.5× 135 0.5× 176 0.7× 111 1.9k
Hans‐Jürgen Pietzsch Germany 28 1.7k 1.1× 564 0.6× 818 0.9× 373 1.4× 406 1.6× 124 2.5k
Kwamena E. Baidoo United States 29 1.4k 0.9× 642 0.7× 537 0.6× 126 0.5× 271 1.1× 51 1.8k
Kevin Maresca United States 30 2.0k 1.4× 1.2k 1.3× 1.2k 1.3× 283 1.1× 622 2.5× 72 3.2k
Thaddeus J. Wadas United States 26 1.7k 1.1× 548 0.6× 1.0k 1.2× 851 3.2× 361 1.4× 53 3.1k
Charles J. Smith United States 29 1.1k 0.7× 537 0.6× 793 0.9× 263 1.0× 634 2.5× 73 2.5k
Alan B. Packard United States 26 1.1k 0.8× 449 0.5× 538 0.6× 250 0.9× 679 2.7× 85 2.6k
Yasushi Arano Japan 31 1.9k 1.3× 695 0.7× 1.0k 1.2× 190 0.7× 665 2.6× 167 3.0k
Carmen Wängler Germany 31 2.1k 1.4× 812 0.9× 928 1.1× 208 0.8× 836 3.3× 127 3.2k

Countries citing papers authored by Mark Bartholomä

Since Specialization
Citations

This map shows the geographic impact of Mark Bartholomä's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Bartholomä with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Bartholomä more than expected).

Fields of papers citing papers by Mark Bartholomä

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Bartholomä. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Bartholomä. The network helps show where Mark Bartholomä may publish in the future.

Co-authorship network of co-authors of Mark Bartholomä

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Bartholomä. A scholar is included among the top collaborators of Mark Bartholomä based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Bartholomä. Mark Bartholomä is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burgard, Caroline, Florian Rosar, Samer Ezziddin, et al.. (2025). [68Ga]Ga-FAPI-04 PET/CT in a patient with endometriosis: a potential game changer?. European Journal of Nuclear Medicine and Molecular Imaging. 52(12). 4350–4351.
2.
Maus, Stephan, et al.. (2025). Radiochemistry of cyclen-derived chelators comprising five-membered azaheterocyclic arms with 212Pb2+, 213Bi3+, and 225Ac3+. Nuclear Medicine and Biology. 146-147. 109034–109034. 3 indexed citations
3.
Schaefer-Schuler, Andrea, Caroline Burgard, Stephan Maus, et al.. (2024). [161Tb]Tb-PSMA-617 radioligand therapy in patients with mCRPC: preliminary dosimetry results and intra-individual head-to-head comparison to [177Lu]Lu-PSMA-617. Theranostics. 14(5). 1829–1840. 22 indexed citations
4.
Rosar, Florian, Caroline Burgard, Mark Bartholomä, et al.. (2024). 225Ac-PSMA-617 Augmentation in High-Risk mCRPC Undergoing 177Lu-PSMA-617 Radioligand Therapy. Clinical Nuclear Medicine. 49(7). 621–629. 5 indexed citations
5.
6.
Rosar, Florian, Caroline Burgard, Robert J. Marlowe, et al.. (2024). Dual FDG/PSMA PET imaging to predict lesion-based progression of mCRPC during PSMA-RLT. Scientific Reports. 14(1). 11271–11271. 6 indexed citations
7.
Stemler, Tobias, Florian Rosar, Caroline Burgard, et al.. (2024). Development of a homotrimeric PSMA radioligand based on the NOTI chelating platform. EJNMMI Radiopharmacy and Chemistry. 9(1). 84–84. 2 indexed citations
8.
Rosar, Florian, Fadi Khreish, Robert J. Marlowe, et al.. (2023). Detection efficacy of [89Zr]Zr-PSMA-617 PET/CT in [68Ga]Ga-PSMA-11 PET/CT-negative biochemical recurrence of prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 50(9). 2899–2909. 13 indexed citations
9.
Linden, Anthony, et al.. (2023). HNODThia: A Promising Chelator for the Development of 64Cu Radiopharmaceuticals. Inorganic Chemistry. 62(50). 20677–20687. 2 indexed citations
10.
Burgard, Caroline, Tobias Stemler, Stephan Maus, et al.. (2023). Radiometal Complexes as Pharmacokinetic Modifiers: A Potent 68Ga-Labeled Gastrin-Releasing Peptide Receptor Antagonist Based on the Macrocyclic Metal Chelator NODIA-Me. Molecular Pharmaceutics. 20(12). 6463–6473. 1 indexed citations
11.
12.
Maus, Stephan, Florian Rosar, Juri Ruf, et al.. (2021). Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617. Journal of Medicinal Chemistry. 64(8). 4960–4971. 18 indexed citations
13.
Jilg, Cordula A., K. Reichel, C. Stoykow, et al.. (2020). Results from extended lymphadenectomies with [111In]PSMA-617 for intraoperative detection of PSMA-PET/CT-positive nodal metastatic prostate cancer. EJNMMI Research. 10(1). 17–17. 18 indexed citations
14.
Lima, Luı́s M. P., David Esteban‐Gómez, Nicolas Le Poul, et al.. (2019). Methylthiazolyl Tacn Ligands for Copper Complexation and Their Bifunctional Chelating Agent Derivatives for Bioconjugation and Copper-64 Radiolabeling: An Example with Bombesin. Inorganic Chemistry. 58(4). 2669–2685. 26 indexed citations
15.
Bartholomä, Mark. (2018). Radioimmunotherapy of solid tumors: Approaches on the verge of clinical application. Journal of Labelled Compounds and Radiopharmaceuticals. 61(9). 715–726. 17 indexed citations
16.
Holland, Jason P., Tilman Läppchen, Harald Scherer, et al.. (2018). Optimized synthesis and indium complex formation with the bifunctional chelator NODIA-Me. Organic & Biomolecular Chemistry. 16(40). 7503–7512. 15 indexed citations
17.
Läppchen, Tilman, et al.. (2017). Gallium Complexation, Stability, and Bioconjugation of 1,4,7-Triazacyclononane Derived Chelators with Azaheterocyclic Arms. Inorganic Chemistry. 56(15). 9097–9110. 28 indexed citations
18.
Bartholomä, Mark, et al.. (2010). [μ-N,N,N′,N′-Tetrakis(2-pyridylmethyl)butane-1,4-diamine]bis[dibromidocopper(II)]. Acta Crystallographica Section E Structure Reports Online. 66(10). m1198–m1198. 7 indexed citations
19.
Bartholomä, Mark, et al.. (2010). [μ-N,N,N′,N′-Tetrakis(2-pyridylmethyl)butane-1,4-diamine]bis[diacetatocadmium(II)] nonahydrate. Acta Crystallographica Section E Structure Reports Online. 66(10). m1195–m1196. 5 indexed citations
20.
Bartholomä, Mark, et al.. (2010). [μ-N,N,N′,N′-Tetrakis(2-pyridylmethyl)pentane-1,5-diamine]bis[dichloridocopper(II)] sesquihydrate. Acta Crystallographica Section E Structure Reports Online. 66(10). m1201–m1202. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cathy S. Cutler Breakdown of academic impact, for papers by Licia Uccelli Breakdown of academic impact, for papers by Hans‐Jürgen Pietzsch Breakdown of academic impact, for papers by Kwamena E. Baidoo Breakdown of academic impact, for papers by Kevin Maresca Breakdown of academic impact, for papers by Thaddeus J. Wadas Breakdown of academic impact, for papers by Charles J. Smith Breakdown of academic impact, for papers by Alan B. Packard Breakdown of academic impact, for papers by Yasushi Arano Breakdown of academic impact, for papers by Carmen Wängler
Rankless by CCL
2026